课题基金 / 基金详情

项目摘要

项目成果

ZHIYI ZUO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): More than 20 million people each year undergo surgery in the U.S.A. Post-operative cognitive dysfunction (POCD), a documented clinical entity that occurs more frequently in elderly patients, has drawn significant attention from the public and professionals. Because the issue is obviously significant, there is an urgent need to identify interventions to attenuate POCD. Our preliminary study showed that amantadine, a clinically used anti-viral agent that is also used in treating various neurodegenerative diseases, reduced surgery (right carotid exploration)-induced learning and memory impairment as well as neuroinflammation in young adult rats. Amantadine also increased glial cell-derived growth factor (GDNF) in the brain. GDNF has been shown to reduce microglial activation in a previous study. In addition, our preliminary study showed that amantadine attenuated surgery-induced learning and memory impairment in elderly rats. We hypothesize that GDNF mediates the amantadine effects on surgery-induced neuroinflammation as well as learning and memory impairment in aged rats. In this project, we will determine whether: 1) the duration of amantadine application affects the effectiveness of amantadine to attenuate surgery-induced learning and memory impairment in aged rats; 2) amantadine reduces surgery-induced neuroinflammation through GDNF; and 3) inhibition of GDNF blocks amantadine-induced attenuation of cognitive impairment after carotid arterial exploration. We will use old adult male rats and subject them to right carotid arterial exploration. Animals will be anesthetized by the volatile anesthetic isoflurane. Learning and memory will be evaluated by Barnes maze and fear conditioning. Various brain regions will be harvested for biochemical examination. These studies may provide preclinical evidence for using amantadine to attenuate POCD. Our studies may also reveal target molecules for the amantadine effects, which may help design interventions for POCD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Obesity-induced cerebral vascular remodeling and poor brain ischemic tolerance
  • 批准号:
    9884819
  • 项目类别:
  • 资助金额:
    $34.81万
  • 财政年份:
    2018
  • 负责人:
    ZHIYI ZUO
  • 依托单位:
Obesity-induced cerebral vascular remodeling and poor brain ischemic tolerance
  • 批准号:
    10380594
  • 项目类别:
  • 资助金额:
    $34.77万
  • 财政年份:
    2018
  • 负责人:
    ZHIYI ZUO
  • 依托单位:
Glial cell line-derived neurotropic factor and postoperative cognitive impairment in young rats
  • 批准号:
    9769801
  • 项目类别:
  • 资助金额:
    $33.51万
  • 财政年份:
    2017
  • 负责人:
    ZHIYI ZUO
  • 依托单位:
Glial cell line-derived neurotropic factor and postoperative cognitive impairment in young rats
  • 批准号:
    10246802
  • 项目类别:
  • 资助金额:
    $32.84万
  • 财政年份:
    2017
  • 负责人:
    ZHIYI ZUO
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: